Latham & Watkins Advised Solace Health In US$130 Million Series C Funding Round

Latham & Watkins Advised Solace Health in US$130 Million Series C Funding Round

Latham & Watkins advised Solace Health has announced a US$130 million Series C funding round led by IVP, accelerating the company’s mission to make advocacy a standard part of care for every patient in the United States. The Series C values Solace at over US$1 billion and reflects growing consensus that healthcare advocacy is no longer optional as costs rise and systems fracture. The round also included participation from existing investors Menlo Ventures, SignalFire, Torch Capital, Inspired Capital, and RiverPark Ventures.

The Latham & Watkins LLP team led by Bay Area Alex Kassai (Partner), with Alec Hampton (Associate), Saul Aguirre‑Villarreal (Associate), and Chris Pham (Associate). Assistance was also provided on the regulatory side by Washington, D.C. Nicole Liffrig Molife (Counsel), and Los Angeles Yanyan Zhou (Counsel), and on the data privacy side by San Diego/San Francisco Jennifer Howes (Counsel), with Zac Alpert (Associate).

Click to know more about Latham & Watkins

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.